Christinawatsoninfo·2d agoHow LENMELDY Gene Therapy Could Be Used as a Treatment for Metachromatic Leukodystrophy (MLD)By Christina Watson
Len Noe·6d agoThe Off Switch Is the Therapy: What the First Human Reprogramming Data Does and Does Not ShowLife Biosciences has treated its first patients with a gene therapy that tries to rewind cells. Three people and fifty-six days say less…
K. Porter·Oct 30Why Gene Therapy Dose Selection Is More Complicated Than It LooksHow vector composition, biological activity, and safety shape dose decisions in cardiovascular gene therapy, using Rocket Pharmaceuticals’…
Nila Kirthiraj·Oct 30The Silent Bleeding DisorderWhat I learned about Hemophilia C, the rare clotting disorder, that sent me to the emergency room.A response icon1A response icon1
Anderson smith·Oct 29How Long Does It Take to Understand Whether a Gene Therapy Is Working?What follow-up, durability, and clinical evidence reveal about treatment response
Wendi Carroll·Oct 28Rare Disease Approvals: Do You Know Where the Data Came From?Why natural history data matters for rare disease approvals, and why patients pay when it is planned too late
Brandian Arias·Oct 20Why Patient Selection Is Critical for Rare Disease Gene Therapy TrialsA gene therapy trial can incorporate an elegant scientific premise and still yield inconclusive results: The right defect could be…
K. Porter·Oct 15So You Want to Work at Rocket Pharmaceuticals? Here’s the Real StoryCranbury’s gene therapy company, decoded. Salaries, workplace culture, career opportunities, and what Google’s AI gets wrong.
CancerFax - Advanced Cancer Treatment·Oct 12Gendicine and Liver Cancer: What Two Decades of p53 Gene Therapy Alongside TACE Actually ShowsGendicine was approved in China in 2003 for one specific cancer: head and neck squamous cell carcinoma. Yet if you spend time in the…
